Introdução: A embolização e a quimioembolização transarterial hepática são procedimentos cirúrgicos usados para tratar pacientes com tumores hepáticos de origem primária e metastática, entretanto causam dor importante no período pós-operatório. O objetivo do estudo foi comparar o bloqueio ...
ABSTRACT BACKGROUND: Transcatheter arterial chemoembolization (TACE) is thought to prevent recurrence of hepatocellular carcinoma (HCC), but its efficacy is a matter of controversy. OBJECTIVES: We investigated the effect of preventive TACE on the tumor, nodes, metastasis (TNM) classification in cases...
Carvalho, Vithor de Oliveira;
Galastri, Francisco Leonardo;
Affonso, Breno Boueri;
Falsarella, Priscila Mina;
Valle, Leonardo Guedes Moreira;
Ferraz-Neto, Ben-Hur;
Rezende, Marcelo Bruno de;
Motta-Leal-Filho, Joaquim Maurício da;
Garcia, Rodrigo Gobbo;
Nasser, Felipe.
ABSTRACT Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially considered unresectable have been enframed...
La quimioembolización transarterial hepática es uno de los tratamientos del carcinoma hepatocelular irresecable en el que se han descrito de forma infrecuente lesiones isquémicas asociadas. Ante la aparición de sintomatología gastrointestinal alta inusual o que exceda el denominado síndrome postqui...
The aim of our study was to assess the efficacy, safety, and prognostic factors of drug-eluting bead transarterial chemoembolization (DEB-TACE) in Chinese hepatocellular carcinoma (HCC) patients. Patients (n=102) diagnosed as primary HCC were consecutively enrolled in this retrospective cohort study. Tre...
Abstract Purpose: To investigate the prognostic value of 17 platelet-based prognostic scores in patients with malignant hepatic tumors after TACE therapy. Methods: In total, 92 patients were divided into death group and survival group according to long-term follow-up results. The AUC was calculated to ...
Aspartato Aminotransferasas/sangre,
Biomarcadores de Tumor/sangre,
Plaquetas/química,
Carcinoma Hepatocelular/sangre,
Carcinoma Hepatocelular/mortalidad,
Carcinoma Hepatocelular/terapia,
Quimioembolización Terapéutica/métodos,
Estimación de Kaplan-Meier,
Neoplasias Hepáticas/sangre,
Neoplasias Hepáticas/mortalidad,
Neoplasias Hepáticas/terapia,
Recuento de Plaquetas,
Pronóstico,
Curva ROC,
Estudios Retrospectivos
Introduction: Hepatocellular carcinoma (HCC) in cirrhosis is diagnosed, most of times, when it is not susceptible to curative treatment. Transarterial chemoembolization (TACE) is a palliative therapeutic option with heterogeneous results. The HAP score stratifies patients who will benefit from the first ...
Carcinoma Hepatocelular/diagnóstico,
Quimioembolización Terapéutica,
Técnicas de Apoyo para la Decisión,
Neoplasias Hepáticas/diagnóstico,
Carcinoma Hepatocelular/mortalidad,
Carcinoma Hepatocelular/terapia,
Estudios de Seguimiento,
Neoplasias Hepáticas/mortalidad,
Neoplasias Hepáticas/terapia,
Perú,
Pronóstico,
Estudios Retrospectivos,
Análisis de Supervivencia
Varghese, Joy;
Kedarisetty, Chandan Kumar;
Venkataraman, Jayanthi;
Srinivasan, Vijaya;
Deepashree, Thiruchunapalli;
Uthappa, Mangerira Chinnappa;
Ilankumaran, Kaliamurthy;
Govil, Sanjay;
Reddy, Mettu Srinivas;
Rela, Mohamed.
ABSTRACT Background & Aim. Transarterial chemoembolization (TACE) or sorafenib is recommended for hepatocellular carcinoma BCLC stages B and C respectively. We studied the role of combination of TACE and sorafenib in BCLC stages B/C. Material and methods. We undertook an observational study on a ...
Antineoplásicos/uso terapéutico,
Carcinoma Hepatocelular/terapia,
Neoplasias Hepáticas/terapia,
Niacinamida/análogos & derivados,
Compuestos de Fenilurea/uso terapéutico,
Inhibidores de Proteínas Quinasas/uso terapéutico,
Antineoplásicos/efectos adversos,
Carcinoma Hepatocelular/etiología,
Carcinoma Hepatocelular/mortalidad,
Carcinoma Hepatocelular/patología,
Quimioembolización Terapéutica/efectos adversos,
Quimioembolización Terapéutica/mortalidad,
Estimación de Kaplan-Meier,
Neoplasias Hepáticas/etiología,
Neoplasias Hepáticas/mortalidad,
Estadificación de Neoplasias,
Niacinamida/efectos adversos,
Niacinamida/uso terapéutico,
Compuestos de Fenilurea/efectos adversos,
Inhibidores de Proteínas Quinasas/efectos adversos,
Factores de Tiempo,
Resultado del Tratamiento,
Carga Tumoral
Carvalho, Sandra R. Almeida;
Ferraz, Maria L. Gomes;
Matos, Carla A. Loureiro;
Silva, Antônio E. Benedito;
Carvalho Filho, Roberto J;
Perez, Rogério Renato;
Gonzalez, Adriano Miziara;
Salzedas-Netto, Alcides A;
Szejnfeld, Denis;
D'Ippolito, Giuseppe;
Lanzoni, Valéria Pereira;
Silva, Ivonete S. Souza.
ABSTRACT Background. Hepatocellular carcinoma (HCC) is the most common malignancy that develops in cirrhotic livers. Its clinical and epidemiological characteristics and mortality rates vary according to geographical region. The objective of this study was to evaluate the clinical profile, epidemiologi...
Técnicas de Ablación,
Antineoplásicos/uso terapéutico,
Carcinoma Hepatocelular/terapia,
Quimioembolización Terapéutica,
Hepatectomía,
Neoplasias Hepáticas/terapia,
Trasplante de Hígado,
Niacinamida/análogos & derivados,
Compuestos de Fenilurea/uso terapéutico,
Centros de Atención Terciaria,
Antineoplásicos/efectos adversos,
Brasil/epidemiología,
Carcinoma Hepatocelular/etiología,
Carcinoma Hepatocelular/mortalidad,
Carcinoma Hepatocelular/patología,
Quimioembolización Terapéutica/efectos adversos,
Quimioembolización Terapéutica/mortalidad,
Hepatectomía/efectos adversos,
Hepatectomía/mortalidad,
Estimación de Kaplan-Meier,
Neoplasias Hepáticas/etiología,
Estadificación de Neoplasias,
Factores de Riesgo,
Factores de Tiempo,
Resultado del Tratamiento,
Carga Tumoral
Chemoembolization for cancer in the head and neck is a challenge. Due to local characteristics and risks, it was used very rarely in the past. By the combination of antineoplastic activity and embolizing effect in the same pharmacon, a routine usage seemed to be possible. A cisplatin suspension in normal...
